EndoFLIP Measurement for Sleeve Gastrectomy GERD Prediction
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research suggests that the EndoFLIP device, which measures the shape and flexibility of the gastroesophageal junction (where the stomach meets the esophagus), can improve surgical outcomes in procedures like fundoplication for GERD. This implies it might help predict GERD after sleeve gastrectomy by providing real-time measurements during surgery.
12345EndoFLIP has been used safely in various surgeries, such as fundoplication and esophagomyotomy, to measure the esophagus and stomach junction. It has been used internationally for several years without reported safety issues.
12346EndoFLIP is unique because it uses a special probe to measure the flexibility and size of the esophagus in real-time during surgery, which can help predict and improve outcomes for GERD (gastroesophageal reflux disease) treatment. This approach is different from traditional methods that do not provide such detailed, immediate feedback during the procedure.
12567Eligibility Criteria
This trial is for adults over 18 with a BMI of 30 or more who can consent to the procedure and have no gastric ulcers. It's not for those with severe esophagitis, Barrett's esophagus, peptic strictures, major swallowing muscle problems, large hiatal hernias (>3 cm), or past stomach surgeries.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
Subjects undergo an upper endoscopy with EndoFLIP before sleeve gastrectomy to measure parameters for prediction model development
Post-operative Follow-up
Subjects may undergo a repeat upper endoscopy with EndoFLIP at 6 months if clinically indicated and complete questionnaires during follow-ups
Long-term Follow-up
Participants complete questionnaires to monitor for gastroesophageal reflux disease and dysphagia up to 5 years